Biotechnology Archives - Page 20 of 32

Bellerophon Stock Plunges 68% After Committee Terminates INOpulse Study

The biotechnology industry can be a tough one. When trials are a success, a company’s stock flies. However, the opposite can occur when trials get rejected. On Tuesday, the latter happened to Bellerophon Therapeutics. After ... [Read]

Progenics Pharmaceuticals receives FDA approval

Progenics Pharmaceuticals’ Stock Gets an 8% Boost After FDA Approval

Jul 31 Chelsea Roh

Progenics Pharmaceuticals receives FDA approval for the first drug to treat rare and extremely life-threatening cancers in patients 12 and older. This approval has boosted the company’s stock exponentially on today’s market. Progenics Pharmaceuticals Receives FDA ... [Read]

Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today

Jul 27 Chelsea Roh

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion. After its twelve-week trial, ... [Read]

resTORbio Inc’s Positive Phase 2b Trial Results Boost Stock 50%

Jul 25 Chelsea Roh

Shares of resTORbio Inc (NASDAQ:TORC) jumped today after the company announced via press release the results of its phase 2 clinical study. The small biotech company has the drug RTB101, which is used to treat ... [Read]

FDA Waives BioPharmX Corporation’s Study and Stock Jumps 16%

Jul 19 Chelsea Roh

FDA waives BioPharmX study, in what many would consider a huge break for the company. FDA Waives BioPharmX Study The Palo Alto-based specialty pharmaceutical company that develops products for dermatologists announced via press release early ... [Read]

FDA: CTI BioPharma Must Conduct A Third Pacritinib Phase 3 Study

Jul 18 Caroline Harris

Today, the FDA requested a third CTI BioPharma Pacritinib phase 3 study. Usually, getting approval from the FDA to start a phase 3 clinical trial on a drug is a good thing. It’s not a good thing, ... [Read]

Shares of Fluoropharma Medical Inc Rally 37.5%

Jun 25 Maria Ohle

Shares of Fluoropharma Medical Inc. (OTCQB:FPMI) have risen a whopping 37.5% on the news that the company has acquired an exclusive option to license meta-Fluorobenzylguanidine (MFBG). MFBG is an imaging agent which has been acquired from ... [Read]

MariMed Shares are Booming Despite Sideways Movement in the Marijuana Index

Jun 19 Siraj Sarwar

MariMed Inc (OTCQB:MRMD): MariMed shares are gaining positive momentum since the start of this year albeit sideways movement in the marijuana index. The North American marijuana index remains range-bound over the last two months after ... [Read]

ObsEva SA Reaches Clinical Trial Endpoint – Shares Jump +25%

Jun 18 Nicky Toor

The Swiss-based biotechnology company ObsEva SA (NASDAQ:OBSV) has announced that it has reached the endpoints of its clinical trial with shares jumping over 25% after the announcement was made. The company, which focuses on developing ... [Read]

Verastem Inc. Announces Stock Offering to Consonance Capital – Share Rise +15%

Jun 15 Nicky Toor

Massachusetts-based biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) announced on Thursday that it would be offering approximately seven million shares of the company’s common stock to Consonance Capital (private). Shares of the company rose over 15% on ... [Read]